Quick Answer
ORAGENICS INC reported Earnings Per Share Diluted of $4.56 (loss) per share for the year ending 2025.
- ORAGENICS INC showed an increase of +90.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ORAGENICS INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $1.85 (loss) per share | Q3 2022: $1.99 (loss) per share | Q1 2023: $1.41 (loss) per share | Q2 2023: $1.51 (loss) per share | Q3 2023: $0.85 (loss) per share | Q1 2024: $0.70 (loss) per share | Q2 2024: $15.27 (loss) per share | Q3 2024: $11.32 (loss) per share | Q1 2025: $0.12 (loss) per share | Q2 2025: $3.10 (loss) per share | Q3 2025: $1.96 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), ORAGENICS INC's Earnings Per Share Diluted has grown by 35.9%.
- Historical annual values: Fiscal year 2025: $4.56 (loss) per share | Fiscal year 2024: $47.88 (loss) per share | Fiscal year 2023: $9.18 (loss) per share | Fiscal year 2022: $7.11 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: